Research is being conducted on the prevention of sarcopenia, or muscle loss, in older adults, particularly in relation to GLP-1 therapy. There are concerns and questions about the potential risk of sarcopenia associated with GLP-1 drugs, which are used to treat conditions such as obesity and type 2 diabetes. The role of nutrition and exercise in preventing muscle loss is also being explored.